SecBot SecBot
PRESS-RELEASE ·Filed Jun 1, 2026

ELAB

PMGC Holdings Inc.
NEUTRAL
Impact 4/10
Horizonmonths Processed4mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight • Neutral

Monitor for definitive purchase agreement and funding details; the non-binding nature and need for audit create high risk of deal failure. Price action likely muted until more concrete terms emerge.

DirectionNeutral
Confidencelow
Horizonmonths
Final — all horizons settled through T+60d
ELAB ▼ -67.85% at T+60d
NEUTRAL call -67.85% · α vs SPY -69.08% · entry $17.70 → $5.69
Entry = T+0 close
Jun 1, 2026
via day close
T+1d
-5.08%
call -5.08% · α -5.22%
$16.80
settled 5mo ago
T+5d
-10.17%
call -10.17% · α -7.62%
$15.90
settled 5mo ago
T+20d
-31.64%
call -31.64% · α -30.34%
$12.10
settled 4mo ago
T+60d
-67.85%
call -67.85% · α -69.08%
$5.69
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

PMGC Holdings (ELAB) announced a non-binding LOI to acquire a 76% controlling interest in a privately held precision machining company for cash. The target generated $5.46M revenue and $1.05M EBITDA in FY2025, with over 20% EBITDA margins. The deal is subject to due diligence, audit, and definitive documentation; no purchase price was disclosed.

Key Facts

  • Non-binding LOI to acquire 76% of a precision machining company
  • Target had $5.46M revenue and $1.05M EBITDA in FY2025
  • Target's adjusted EBITDA margin >20% on trailing twelve months
  • Target is AS9100 compliant, ISO 9001:2015, ITAR registered
  • Acquisition consideration is cash, amount subject to due diligence
  • Expected closing before Q4 2026, contingent on audit and definitive agreement

Financial Impact

Target's EBITDA of $1.05M represents ~13% of PMGC's $8M market cap, but deal value and financing terms are undisclosed.

revenueebitdadilution

Risk Factors

  • Non-binding LOI may not lead to a definitive agreement
  • Deal value and financing terms unknown; potential for shareholder dilution if cash is raised
  • Audited financials may differ materially from unaudited figures provided

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3304257
27 reports for ELAB
Performance horizon
33% Hit rate @ T+1 2 of 6 directional calls Went positive at some point 2 of 6 best @ T+60▲ +66.87%Apr 20, 2026
Filters
Rows
Reports for ELAB — sortable, filterable
TypeNow
Sep 29, 2026
28d ago
Press Release
NEUTRAL ★ 3/10
$3.67 $3.54▼ −3.54%▼ −3.34%$2.52 (−31.35%)
Sep 18, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$4.78 $4.42▼ −7.53%▼ −9.08%$2.52 (−47.29%)
Sep 18, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$4.78 $4.42▼ −7.53%▼ −9.08%$2.52 (−47.29%)
Aug 19, 2026
9w ago
Press Release
NEUTRAL ★ 3/10
$0.5603 $0.6100▲ +8.87%▲ +9.71%$2.52 (+349.67%)
Aug 14, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$0.9100 $0.8730▼ −4.07%▼ −3.59%$2.52 (+176.87%)
Jul 29, 2026
12w ago
Press Release
NEUTRAL ★ 3/10
$0.8800 $0.9493▲ +7.88%▲ +6.20%$2.52 (+186.31%)
Jul 9, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$1.12 $1.09▼ −2.68%▼ −1.91%$2.52 (+124.96%)
Jul 1, 2026
16w ago
8-K
BULLISH ★ 5/10
$1.28 $1.18▼ −7.81%▼ −7.68%$2.52 (+96.84%)
Jun 8, 2026
20w ago
Press Release
NEUTRAL ★ 4/10
$1.59 $1.41▼ −11.32%▼ −11.03%$2.52 (+58.46%)
Jun 5, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$1.59 $1.41▼ −11.32%▼ −11.03%$2.52 (+58.46%)
Showing 10 of 27

US Market Status

Market Open — Closes in 4h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026